Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass far faster than those who end conventional lifestyle programs.
Findings released in a leading medical journal demonstrates that while obese individuals often shed substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals using such medications should be aware of the potential of fast weight regain when the medication ends," stated researcher Dr. Susan Jebb.
This pace of recovery implies a return to starting weight in about one and a half years.
Comparing Therapies
The research, which reviewed 37 of trials involving thousands of participants, compared the outcomes of the injectable medications with conventional dieting.
Researchers note that people who shed pounds through dieting usually experience a less rapid weight regain—around 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Nutrition scientists propose the mode of action of the jabs accounts for the accelerated weight return.
The injections imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal may cause the body to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication means hunger is no longer kept in check, making overeating much more probable."
A Lifelong Disease?
Health authorities recommend the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, considering the high risk of relapse, the therapy might need to be ongoing.
This perspective is supported by drug manufacturers, who say that the results "emphasize the chronic nature of obesity," similar to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the medication describe a sudden return of cravings.
"It felt as if a switch flipping and you become ravenous," described one woman.
This challenge is compounded if patients have not adopted permanent lifestyle or habit changes during treatment.
Growing Adoption
Survey data show that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.
- Use is greater among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, clinicians caution that while these medications are potent agents for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on combined lifestyle changes.
